Acurx Site #107: Dr Belkis Delgado — Miami Springs, Florida

Acurx Site #107: Dr Belkis Delgado is a clinical research site located in Miami Springs, Florida, United States 33166.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Acurx Site #107: Dr Belkis Delgado has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Acurx Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami Springs

Browse all research sites in Florida · View every site in Miami Springs

• Ocean Blue Medical Research Center
• Research Site
• Galiz Research
• South Florida Research Phase I-IV
• Synergy Research Site
• Miami Springs
• South Florida Research Ph I-IV /ID# 252350
• Novo Nordisk Investigational Site
• Neumora Investigator Site
• Salix Investigational Site
• GSK Investigational Site
• South Florida Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acurx Site #107: Dr Belkis Delgado?

Acurx Site #107: Dr Belkis Delgado has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acurx Site #107: Dr Belkis Delgado conducted?

Acurx Site #107: Dr Belkis Delgado has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Acurx Site #107: Dr Belkis Delgado accredited by Crixeo Clinical Trials?

Acurx Site #107: Dr Belkis Delgado has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acurx Site #107: Dr Belkis Delgado?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.